Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting

Britta Noebauer1, Lejla Ramic1, Andrea Konstantin1

  • 1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Biochemia Medica
|November 29, 2017
PubMed

Insights

A new automated assay for fecal calprotectin (FC) measurement in children shows good performance. This particle-enhanced turbidimetric immunoassay (PETIA) on the VITROS® 5600 analyzer offers a reliable option for diagnosing inflammatory bowel disease (IBD).

Area of Science:

  • Clinical chemistry
  • Immunodiagnostics
  • Pediatric gastroenterology

Background:

  • Faecal calprotectin (FC) is a key biomarker for pediatric inflammatory bowel disease (IBD).
  • Non-invasive FC testing aids in screening children with gastrointestinal symptoms, reducing the need for invasive procedures.
  • Evaluating new automated assays is crucial for efficient laboratory diagnostics.

Purpose of the Study:

  • To validate the performance of a fully automated particle-enhanced turbidimetric immunoassay (PETIA) for measuring fecal calprotectin (FC).
  • To assess the suitability of the VITROS® 5600 analyzer for routine FC determination in symptomatic children and adolescents.

Main Methods:

  • Performance characteristics including limit of quantitation (LoQ), linearity, and precision were determined for the PETIA assay.
  • Calibration curve stability was assessed over a 4-week period.
  • Agreement was evaluated by comparing PETIA results with ELISA and a semi-quantitative lateral flow assay using 95 fecal samples.

Main Results:

  • The PETIA assay demonstrated an LoQ of 21 µg/g and a linearity range of 20-2100 µg/g.
  • Precision studies showed a total coefficient of variation (CV) between 2.3% and 8.9%.
  • Good agreement was observed between the PETIA assay and established methods (ELISA, lateral flow assay) via regression analysis and Bland-Altman plots.

Conclusions:

  • The fully automated PETIA on the VITROS® 5600 analyzer exhibits robust performance characteristics.
  • This assay demonstrates good agreement with existing methods for FC measurement.
  • It represents a valuable new analytical option for rapid FC determination in pediatric IBD screening.
Abstract

Related Concept Videos